• Protocols

• LUNGMAP

  OPEN TO ACCRUAL

  A Master Protocol to Evaluate Biomarker-Driven Therapies + Immunotherapies in Previously-Tx'd NSCLC
  
  

• S1800E

  OPEN TO ACCRUAL

  Ph 2, 3 Study of Docetaxel and Ramucirumab + or - Cemiplimab for Participants with NSCLC